Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Leonardo Espinel

Surgery Culpeper, VA Medical Doctor

NPI 1871555995 CMS profile 1303228

541 Sunset Ln Ste 103, Culpeper, VA 22701

Open in the dashboard

General payments

$30,838

49 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Leonardo Espinel of Culpeper, VA is reported in the CMS Open Payments database as having received $30,838 across 49 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $1,053 10
2022 General $704 7
2021 General $10,268 10
2020 General $4,498 7
2019 General $14,315 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leonardo Espinel
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Leonardo Espinel were reported at $0. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Leonardo Espinel Surgery median Middle half National median
2019 $14,315 $253 $82–$1,521 $163
2020 $4,498 $131 $40–$706 $114
2021 $10,268 $168 $50–$904 $132
2022 $704 $224 $76–$1,218 $149
2023 $1,053 $253 $82–$1,255 $160
2024 $0 $279 $90–$1,381 $164
2025 $0 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Intuitive Surgical, Inc. $30,701 47 payments
  2. Olympus America Inc. $113 1 payment
  3. Medtronic, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Education $24,000 6 payments
  2. Travel and Lodging $4,864 21 payments
  3. Food and Beverage $1,975 22 payments
Products named General payments · program years 2019–2023
  1. Da Vinci Surgical System $30,701 47 payments
  2. Olympus Biliary Devices $113 1 payment
  3. EndoFlip $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

202

Median for General Surgery: 59

Drug cost

$3,341

Median for General Surgery: $393

Branded share of claims

61.4%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 35 $2,192
Pantoprazole Sodium Generic 35 $362
Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 16 $224
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 14 $173
Sucralfate Generic 28 $139
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 59 $135
Omeprazole Generic 15 $116

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$63,063

Medicare's payments for the services billed

Medicare patients

215

Average age 74

Services billed

401

97 women, 118 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 40%
Diabetes 30%
Chronic kidney disease 25%
Atrial fibrillation 22%
Ischemic heart disease 20%
COPD 19%
Depression 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

49 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record